Patents/Assignees

BIOVERATIV THERAPEUTICS Inc.

18 patents in portfolio

US12617839utility2026
Factor VIII Chimeric Proteins and Uses Thereof
0 cites
US12570691utility2026
Purification of Chimeric FVIII Molecules
0 cites
US12551404utility2026
Device Container
0 cites
US12403183utility2025
Factor VIII Polypeptide Formulations
0 cites
US12364774utility2025
Nucleic Acid Molecules and Uses Thereof for Non-viral Gene Therapy
0 cites
US12275970utility2025
Optimized Factor IX Gene
0 cites
US12186375utility2025
Factor VIII Chimeric and Hybrid Polypeptides, and Methods of Use Thereof
0 cites
US12168776utility2024
Nucleic Acid Molecules and Uses Thereof
0 cites
US12161696utility2024
Methods of Treating Hemophilic Arthropathy Using Chimeric Clotting Factors
0 cites
US12134632utility2024
On-column Viral Inactivation Methods
0 cites
US12128092utility2024
Lyophilized Factor IX Formulations
0 cites
US12030925utility2024
Methods of Treating Hemophilia A
0 cites
US11787851utility2023
Optimized Factor VIII Gene
0 cites
US11753461utility2023
Optimized Factor VIII Genes
0 cites
US11747351utility2023
Assays to Monitor Bleeding Disorders
0 cites
US11685771utility2023
Recombinant Factor VIII Proteins
0 cites
US11642398utility2023
Factor IX Polypeptide Formulations
0 cites
US11578098utility2023
On-column Viral Inactivation Methods
0 cites